المؤلفون: Jianguo Zhi, Franziska Schaedeli Stark, Kai Habben, Angelika Lahr, Jean Tessier, Roland F Staack, Eginhard Schick, Ka Wang, Tilman Schlothauer, Oliver Krieter, Valerie Cosson

المصدر: Cancer Chemotherapy and Pharmacology. 79:661-671

مصطلحات موضوعية: Male, 0301 basic medicine, Placental growth factor, Sorafenib, Cancer Research, Bevacizumab, Population, Angiogenesis Inhibitors, Pharmacology, Antibodies, Monoclonal, Humanized, Toxicology, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Pharmacokinetics, Neoplasms, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Drug Interactions, Pharmacology (medical), education, Sex Characteristics, education.field_of_study, Models, Statistical, Dose-Response Relationship, Drug, business.industry, Antibodies, Monoclonal, Membrane Proteins, Cancer, medicine.disease, Vascular endothelial growth factor, 030104 developmental biology, Oncology, chemistry, 030220 oncology & carcinogenesis, Female, Ovarian cancer, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d9fd7b90e0e4fecc70b0ef6c1aa0696Test
https://doi.org/10.1007/s00280-017-3242-8Test

المؤلفون: Oliver Krieter, Jean Tessier, Ka Wang, Angelika Lahr, Michael Weller, Maryline Barrie, Morten Mau-Sørensen, Catherine McBain, Patrick Roth, Olivier Chinot, Vibeke Andrée Larsen, Ulrik Lassen, Kai Habben

المساهمون: University of Zurich, Lassen, U

المصدر: Neuro-oncology. 17(7)

مصطلحات موضوعية: Adult, Male, Cancer Research, medicine.medical_specialty, Combination therapy, Bevacizumab, Clinical Investigations, 610 Medicine & health, Angiogenesis Inhibitors, Kaplan-Meier Estimate, Pharmacology, Pregnancy Proteins, Antibodies, Monoclonal, Humanized, Gastroenterology, Pharmacokinetics, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, 1306 Cancer Research, Dosing, Adverse effect, Aged, Placenta Growth Factor, business.industry, Brain Neoplasms, Antibodies, Monoclonal, Middle Aged, medicine.disease, 10040 Clinic for Neurology, 2728 Neurology (clinical), Treatment Outcome, Oncology, Tolerability, Pharmacodynamics, 2730 Oncology, Female, Neurology (clinical), Neoplasm Recurrence, Local, business, Glioblastoma, Meningitis, medicine.drug

وصف الملف: N-O-D-14-00600R2_Lassen_FINAL.pdf - application/pdf; nov019.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8137f907980375accb6331e2316faddfTest
https://pubmed.ncbi.nlm.nih.gov/25665807Test

المؤلفون: Claus-Peter Schneider, Lian Liu, Lucio Crinò, Martin Reck, Pasi A. Jänne, Martin Steins, Silvia Novello, David Y. Chen, Wilfried Eberhardt, David R. Spigel, Suresh S. Ramalingam, Carrie Brownstein, Kai Habben, Jeffrey A. Engelman

مصطلحات موضوعية: Oncology, Male, Cancer Research, medicine.medical_specialty, Lung Neoplasms, medicine.medical_treatment, Medizin, Phases of clinical research, Pharmacology, Placebo, Antibodies, Monoclonal, Humanized, Disease-Free Survival, Receptor, IGF Type 1, Placebos, Insulin-like growth factor, Erlotinib Hydrochloride, Internal medicine, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Epidermal growth factor receptor, Lung cancer, Performance status, biology, business.industry, Antibodies, Monoclonal, ORIGINAL REPORTS, Middle Aged, medicine.disease, biology.protein, Quinazolines, Female, Erlotinib, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::843c8a874ab077ac8be80047c1268f0cTest
http://hdl.handle.net/2318/104357Test